Skip to main content
Top
Published in: Journal of Neurology 12/2017

01-12-2017 | Original Communication

The natural history of depressive symptoms in patients with incident Parkinson’s disease: a prospective cohort study

Authors: Jan Petter Larsen, Ingvild Dalen, Kenn Freddy Pedersen, Ole-Bjørn Tysnes

Published in: Journal of Neurology | Issue 12/2017

Login to get access

Abstract

Depression is common in patients with Parkinson disease and causes suffering and increased caregiver burden. A better understanding of depressive symptoms in Parkinson disease, their progression, and risk factors may, therefore, benefit management of these patients. The present study included 187 drug-naïve patients with incident PD and 166 controls from the population-based Norwegian ParkWest project. Depressive symptoms were examined with the Montgomery and Aasberg Depression Rating Scale (MADRS) at time of diagnosis and inclusion in the study and after 1, 3, 5, and 7 years of follow-up. Associations between MADRS scores and risk factors were assessed using generalized estimating equations (GEE). The mean MADRS score from all 823 examinations during the study period was 4.2 in patients and 1.3 in 732 examinations among controls. Among controls, the occurrence of depressive symptoms was also lower and rather stable during follow-up, while in patients, we observed a decrease from time of diagnosis and until the 1-year visit, followed by a steady increase in these symptoms over time. Factors associated with higher MADRS score in the multivariable model were female sex, being dependent, higher pain score, higher Unified PD Rating Scale (UPDRS) motor score, and lower Mini-Mental State Examination (MMSE) score. The results from this study underscore the importance and frequency of depressive symptoms in patients with early PD. Furthermore, risk factors that may be considered PD-nonspecific are associated with depressive symptoms as are factors that reflect the progression of PD.
Literature
1.
go back to reference Blazer DG (2003) Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 58:249–265CrossRefPubMed Blazer DG (2003) Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 58:249–265CrossRefPubMed
2.
go back to reference Cole M, Dendukuri N (2003) Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry 160:1147–1156CrossRefPubMed Cole M, Dendukuri N (2003) Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry 160:1147–1156CrossRefPubMed
3.
go back to reference Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF (2008) A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 23:183–189CrossRefPubMed Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF (2008) A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 23:183–189CrossRefPubMed
5.
go back to reference Vu TC, Nutt JG, Holford NH (2012) Progression of motor and nonmotor features of Parkinson’s disease and their response to treatment. Br J Clin Pharmacol 74:267–283CrossRefPubMedPubMedCentral Vu TC, Nutt JG, Holford NH (2012) Progression of motor and nonmotor features of Parkinson’s disease and their response to treatment. Br J Clin Pharmacol 74:267–283CrossRefPubMedPubMedCentral
6.
go back to reference Bega D, Luo S, Fernandez H et al (2015) Impact of depression on progression of impairment and disability in early Parkinson’s disease. Mov Disord Clin Pract 2:371–378CrossRefPubMedPubMedCentral Bega D, Luo S, Fernandez H et al (2015) Impact of depression on progression of impairment and disability in early Parkinson’s disease. Mov Disord Clin Pract 2:371–378CrossRefPubMedPubMedCentral
7.
go back to reference Aarsland D, Påhlhagen S, Ballard CG, Ehrt U, Svenningsson P (2011) Depression in Parkinson disease—epidemiology, mechanisms and management. Nat Rev Neurol 8:35–47CrossRefPubMed Aarsland D, Påhlhagen S, Ballard CG, Ehrt U, Svenningsson P (2011) Depression in Parkinson disease—epidemiology, mechanisms and management. Nat Rev Neurol 8:35–47CrossRefPubMed
8.
go back to reference Suzuki A, Aoshima T, Fukasawa T et al (2005) A three-factor model of the MADRS in major depressive disorder. Depress Anxiety 21:95–97CrossRefPubMed Suzuki A, Aoshima T, Fukasawa T et al (2005) A three-factor model of the MADRS in major depressive disorder. Depress Anxiety 21:95–97CrossRefPubMed
9.
go back to reference Leentjens AF, Moonen AJ, Dujardin K et al (2013) Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors. Neurology 81:1036–1043CrossRefPubMedPubMedCentral Leentjens AF, Moonen AJ, Dujardin K et al (2013) Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors. Neurology 81:1036–1043CrossRefPubMedPubMedCentral
10.
go back to reference Alves G, Muller B, Herlofson K et al (2009) Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 80:851–857CrossRefPubMed Alves G, Muller B, Herlofson K et al (2009) Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 80:851–857CrossRefPubMed
11.
go back to reference Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology 42:1142–1146CrossRefPubMed Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology 42:1142–1146CrossRefPubMed
12.
go back to reference Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39CrossRefPubMed Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39CrossRefPubMed
13.
go back to reference Fahn S, Elton RL, Development Committee UPDRS (1987) Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan, Florham Park, pp 153–163 Fahn S, Elton RL, Development Committee UPDRS (1987) Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan, Florham Park, pp 153–163
14.
go back to reference Jankovic J, McDermott M, Carter J et al (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40:1529–1534CrossRefPubMed Jankovic J, McDermott M, Carter J et al (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40:1529–1534CrossRefPubMed
15.
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
16.
go back to reference Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653CrossRefPubMed Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653CrossRefPubMed
17.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed
18.
go back to reference de Groot V, Beckerman H, Lankhorst GJ, Bouter LM (2003) How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 56:221–229CrossRefPubMed de Groot V, Beckerman H, Lankhorst GJ, Bouter LM (2003) How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 56:221–229CrossRefPubMed
19.
go back to reference Schwab JF, England AC (1969) Projection technique for evaluating surgery in Parkinson’s disease. In: Gillingham FJ, Donaldson IML (eds) Third symposium on Parkinson’s disease. E & S Livingston, Edinburgh, pp 152–157 Schwab JF, England AC (1969) Projection technique for evaluating surgery in Parkinson’s disease. In: Gillingham FJ, Donaldson IML (eds) Third symposium on Parkinson’s disease. E & S Livingston, Edinburgh, pp 152–157
20.
go back to reference Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389CrossRefPubMed Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389CrossRefPubMed
21.
22.
go back to reference Snaith RP, Harrop FM, Newby PA, Teale C (1986) Grade scores of the Montgomery-Asberg depression and the clinical anxiety scales. Br J Psychiatry 148:599–601CrossRefPubMed Snaith RP, Harrop FM, Newby PA, Teale C (1986) Grade scores of the Montgomery-Asberg depression and the clinical anxiety scales. Br J Psychiatry 148:599–601CrossRefPubMed
23.
go back to reference Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW (2000) The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson’s disease. Int J Geriatr Psychiatry 15:644–649CrossRefPubMed Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW (2000) The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson’s disease. Int J Geriatr Psychiatry 15:644–649CrossRefPubMed
24.
go back to reference Cummings JL, Mega M, Gray K et al (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314CrossRefPubMed Cummings JL, Mega M, Gray K et al (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314CrossRefPubMed
25.
go back to reference Kurland BF, Heagerty PJ (2005) Directly parameterized regression conditioning on being alive: analysis of longitudinal data truncated by deaths. Biostatistics 6:241–258CrossRefPubMed Kurland BF, Heagerty PJ (2005) Directly parameterized regression conditioning on being alive: analysis of longitudinal data truncated by deaths. Biostatistics 6:241–258CrossRefPubMed
27.
go back to reference Barone P, Poewe W, Albrecht S et al (2010) Pramipexole for the treatment of depressive symptoms in patients with Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:573–580CrossRefPubMed Barone P, Poewe W, Albrecht S et al (2010) Pramipexole for the treatment of depressive symptoms in patients with Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:573–580CrossRefPubMed
28.
go back to reference Xu YY, Kuo SH, Liang Z et al (2015) The natural history of depression in Parkinson’s disease within 30-month follow-up. Parkinsons Dis 2015:362892PubMedPubMedCentral Xu YY, Kuo SH, Liang Z et al (2015) The natural history of depression in Parkinson’s disease within 30-month follow-up. Parkinsons Dis 2015:362892PubMedPubMedCentral
29.
go back to reference Marsh L, McDonald WM, Cummings J, Ravina B (2006) Provisional diagnostic criteria for depression in Parkinson’s disease: report of an NINDS/NIMH Work Group. Mov Disord 21:148–158CrossRefPubMed Marsh L, McDonald WM, Cummings J, Ravina B (2006) Provisional diagnostic criteria for depression in Parkinson’s disease: report of an NINDS/NIMH Work Group. Mov Disord 21:148–158CrossRefPubMed
30.
go back to reference Stek ML, Vinkers DJ, Gussekloo J, van der Mast RC, Beekman AT, Westendorp RG (2006) Natural history of depression in the oldest old: population-based prospective study. Br J Psychiatry 188:65–69CrossRefPubMed Stek ML, Vinkers DJ, Gussekloo J, van der Mast RC, Beekman AT, Westendorp RG (2006) Natural history of depression in the oldest old: population-based prospective study. Br J Psychiatry 188:65–69CrossRefPubMed
31.
go back to reference Leentjens AF, Moonen AJ, Dujardin K et al (2013) Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors. Neurology 81:1036–1043CrossRefPubMedPubMedCentral Leentjens AF, Moonen AJ, Dujardin K et al (2013) Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors. Neurology 81:1036–1043CrossRefPubMedPubMedCentral
32.
go back to reference Chen JJ, Marsh L (2013) Depression in Parkinson’s disease: identification and management. Pharmacotherapy 33:972–983CrossRefPubMed Chen JJ, Marsh L (2013) Depression in Parkinson’s disease: identification and management. Pharmacotherapy 33:972–983CrossRefPubMed
Metadata
Title
The natural history of depressive symptoms in patients with incident Parkinson’s disease: a prospective cohort study
Authors
Jan Petter Larsen
Ingvild Dalen
Kenn Freddy Pedersen
Ole-Bjørn Tysnes
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 12/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8638-1

Other articles of this Issue 12/2017

Journal of Neurology 12/2017 Go to the issue